ARAurélie Russo

Aurélie Russo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Aurélie Russo has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • C. Dot

    Service d'ophtalmologie, hôpital d'instruction des armées Desgenettes, 108, boulevard Pinel, 69003 Lyon, France

    1 shared publication
  • C. Lagenaite

    Service d'ophtalmologie, hôpital d'instruction des armées Desgenettes, 108, boulevard Pinel, 69003 Lyon, France

    1 shared publication
  • Corinne Dot

    Department of Ophthalmology, Hôpital Edouard Herriot, Centre Hospitalier Universitaire de Lyon Grange Blanche, 5, Place d’Arsonval, 69437 Lyon, France

    1 shared publication
  • E. Agard

    Service d'ophtalmologie, hôpital d'instruction des armées Desgenettes, 108, boulevard Pinel, 69003 Lyon, France

    1 shared publication
  • Emilie Agard

    Department of Ophthalmology, Desgenettes Military Hospital, Lyon, France

    1 shared publication
  • G. Ract-Madoux

    Service d'ophtalmologie, hôpital d'instruction des armées Desgenettes, 108, boulevard Pinel, 69003 Lyon, France

    1 shared publication

Latest Publications

  • Intraocular Pressure Spikes after Aflibercept Intravitreal Injections

    by Hussam El Chehab, Emilie Agard, Aurélie Russo, Ygal Boujnah, Corinne Dot

    The objective of this study was to assess the intraocular pressure (IOP) as well as the anatomical modifications of the anterior segment following an aflibercept injection. Patients underwent an aflibercept intravitreal injection (IVI) (0.05 ml) with a 30.5-gauge needle and an antireflux system. IOP was assessed before injection (T0), immediately after (T1), and 5 min (T5), 15 min (T15), and 45 min (T45) after the IVI. Before the IVI and immediately after the T1 measurement, a PENTACAM® acquisition was used to evaluate the anterior chamber parameters (anterior chamber volume, depth and measure of the iridocorneal angle). At T0, IOP was 12.9 ± 1.3 mm Hg. IOP significantly increased after IVI (42.7 ± 3 mm Hg, p < 0.001). IOP returned to baseline at T45 (13.0 ± 1.2 mm Hg, p = 0.877). Anterior chamber volume decreased after IVI (160.6 vs. 168.3 mm3, p = 0.002). No significant changes were found for iridocorneal angle and anterior chamber depth. Aflibercept IVI causes an acute increase in IOP over a short period without iridocorneal angle closure.


  • Rétinopathie de haute altitude : à propos de 3 cas

    by A. Russo, E. Agard, J.-P. Blein, H. El Chehab, C. Lagenaite, G. Ract-Madoux, C. Dot